Jeroen Bakker

Jeroen Bakker is a board member at ADCendo. Prior to that, they were with ISD-Immunotech, Rappta Therapeutics, and Inthera Bioscience, where they served as Interim Chief Operations Officer from September 2020 to April 2021. Jeroen has also been with Antag Therapeutics, BiOrigin, Novo Holdings, and M Ventures.

Jeroen Bakker attended the High Performance Boards Program at IMD, the Financing the entrepreneurial business program at London Business School, and earned their Doctor of Philosophy in Immunology from University of Amsterdam. Jeroen also holds a Master of Science in Immunology from Leiden University and a Bachelor of Science in Biotechnology from Delft University of Technology.